{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:40:02Z","timestamp":1749948002381,"version":"3.41.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Varicella infects 90% of children before age 9. Though varicella is self-limiting, its complications may require antibiotics, though how antibiotics are utilized for varicella in France is not well known. This study assessed antibiotic use and costs associated with varicella and its complications in pediatric patients managed in the outpatient setting in France.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective cohort study using the Cegedim Strategic Data-Longitudinal Patient Database, an electronic medical record database from general practitioners and office-based specialists in France, was conducted. Children &lt;18 years old diagnosed with varicella between January 2014 and December 2018 with 3-month follow-up available were included. We used descriptive analysis to assess varicella-related complications, medication use, healthcare resource utilization and costs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Overall, 48,027 patients were diagnosed with varicella; 15.3% (n = 7369) had \u22651 varicella-related complication. Antibiotics were prescribed in up to 25.1% (n = 12,045\/48,027) of cases with greater use in patients with complications (68.1%, n = 5018\/7369) compared with those without (17.3%, n = 7027\/40,658). Mean medication and outpatient varicella-related costs were \u20ac32.82 per patient with medications costing a mean of \u20ac5.84 per patient; antibiotics contributed ~23% to total costs annually.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study showed high antibiotic use for the management of varicella and its complications. A universal varicella vaccination program could be considered to alleviate complications and associated costs in France.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004254","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T14:07:14Z","timestamp":1709906834000},"page":"393-399","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and Economic Burden of Antibiotic Use Among Pediatric Patients With Varicella Infection in the Outpatient Setting: A Retrospective Cohort Analysis of Real-world Data in France"],"prefix":"10.1097","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7915-8553","authenticated-orcid":false,"given":"Stephanie A.","family":"Kujawski","sequence":"first","affiliation":[{"name":"From the Center for Observational and Real-world Evidence, Merck & Co., Inc., Rahway, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline S.","family":"Casey","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Bollington, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Haas","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Neonatalogy, Centre Hospitalier Princesse Grace, Monaco."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amisha","family":"Patel","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Bollington, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Diomatari","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Bollington, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Holbrook","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Bollington, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjiri","family":"Pawaskar","sequence":"additional","affiliation":[{"name":"From the Center for Observational and Real-world Evidence, Merck & Co., Inc., Rahway, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/archdischild-2015-308283","article-title":"Varicella paediatric hospitalisations in Belgium: a 1-year national survey.","volume":"101","author":"Blumental","year":"2016","journal-title":"Arch Dis Child"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ncl.2008.03.011","article-title":"Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.","volume":"26","author":"Mueller","year":"2008","journal-title":"Neurol Clin"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/21645515.2018.1546525","article-title":"Global impact of varicella vaccination programs.","volume":"15","author":"Varela","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/INF.0000000000002233","article-title":"Implementing universal varicella vaccination in Europe: the path forward.","volume":"38","author":"Spoulou","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection.","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12879-017-2445-2","article-title":"Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.","volume":"17","author":"Riera-Montes","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1186\/s12889-021-12343-x","article-title":"Economic burden of varicella in Europe in the absence of universal varicella vaccination.","volume":"21","author":"Pawaskar","year":"2021","journal-title":"BMC Public Health"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/21645515.2018.1559687","article-title":"Varicella healthcare resource utilization in middle income countries: a pooled analysis of the multi-country MARVEL study in Latin America & Europe.","volume":"15","author":"Wolfson","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1186\/s12879-021-06848-4","article-title":"Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis.","volume":"21","author":"Vandenhaute","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1741-7015-7-26","article-title":"Varicella vaccination in Europe - taking the practical approach.","volume":"7","author":"Bonanni","year":"2009","journal-title":"BMC Med"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.pop.2018.05.006","article-title":"Emergence of global antibiotic resistance.","volume":"45","author":"Morehead","year":"2018","journal-title":"Prim Care"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/antibiotics11050643","article-title":"Outpatient antibiotic prescriptions in France: patients and providers characteristics and impact of the COVID-19 pandemic.","volume":"11","author":"Bara","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/ijerph16010027","article-title":"Drivers of irrational use of antibiotics in Europe.","volume":"16","author":"Machowska","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/pds.2203","article-title":"Validation of the health improvement network (THIN) database for epidemiologic studies of chronic kidney disease.","volume":"20","author":"Denburg","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research.","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/14760584.2019.1573145","article-title":"Burden of varicella in Central and Eastern Europe: findings from a systematic literature review.","volume":"18","author":"M\u00e9szner","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"1900233","DOI":"10.2807\/1560-7917.ES.2019.24.42.1900233","article-title":"Burden of varicella complications in secondary care, England, 2004 to 2017.","volume":"24","author":"Bernal","year":"2019","journal-title":"Euro Surveill"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/adc.2007.123232","article-title":"Severe complications of chickenpox in hospitalised children in the UK and Ireland.","volume":"92","author":"Cameron","year":"2007","journal-title":"Arch Dis Child"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1542\/hpeds.2017-0086","article-title":"Study of complications of varicella-zoster virus infection in hospitalized children at a reference hospital for infectious disease treatment.","volume":"8","author":"Diniz","year":"2018","journal-title":"Hosp Pediatr"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7748\/ns2014.04.28.33.52.e8249","article-title":"Varicella zoster virus: chickenpox and shingles.","volume":"28","author":"Gould","year":"2014","journal-title":"Nurs Stand"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s40121-019-00273-6","article-title":"Specific varicella-related complications and their decrease in hospitalized children after the introduction of general varicella vaccination: results from a multicenter pediatric hospital surveillance study in Bavaria (Germany).","volume":"8","author":"Hagemann","year":"2019","journal-title":"Infect Dis Ther"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/INF.0b013e3181586665","article-title":"The burden of varicella complications before the introduction of routine varicella vaccination in Germany.","volume":"27","author":"Liese","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/INF.0000000000001656","article-title":"Varicella-related primary health-care visits, hospitalizations and mortality in Norway, 2008-2014.","volume":"36","author":"Mirinaviciute","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00431-019-03332-9","article-title":"Epidemiological and clinical characteristics and the approach to infant chickenpox in primary care.","volume":"178","author":"Rodriguez-Santana","year":"2019","journal-title":"Eur J Pediatr"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/INF.0b013e3181e2817f","article-title":"Complications of varicella after implementation of routine childhood varicella vaccination in Germany.","volume":"29","author":"Spackova","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00431-005-0043-6","article-title":"Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introduction.","volume":"165","author":"Theodoridou","year":"2006","journal-title":"Eur J Pediatr"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.vaccine.2014.04.034","article-title":"Low varicella-related consultation rate in the Netherlands in primary care data.","volume":"32","author":"van Lier","year":"2014","journal-title":"Vaccine"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2340\/00015555-0333","article-title":"Bacterial skin infections in children hospitalized with varicella: a possible negative impact of non-steroidal anti-inflammatory drugs?.","volume":"88","author":"Dubos","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1469-0691.2007.01706.x","article-title":"Paediatric varicella hospitalisations in France: a nationwide survey.","volume":"13","author":"Grimprel","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"R37-20250614","first-page":"jiad420","article-title":"The clinical and economic burden of antibiotic use in pediatric patients with varicella infection: a retrospective cohort analysis of real-world data in England [published online ahead of print].","author":"Kujawski","year":"2023","journal-title":"J Infect Dis"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/13696998.2018.1431919","article-title":"Economic burden of varicella in children 1\u201312 years of age in Argentina, 2009\u20132014.","volume":"21","author":"Giglio","year":"2018","journal-title":"J Med Econ"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/INF.0b013e31829ae263","article-title":"The effectiveness of varicella vaccination in children in Germany: a case-control study.","volume":"32","author":"Liese","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"Supplement_4","key":"R40-20250614","doi-asserted-by":"crossref","first-page":"S407","DOI":"10.1093\/infdis\/jiac242","article-title":"Decline in severe varicella disease during the United States varicella vaccination program: hospitalizations and deaths, 1990\u20132019.","volume":"226","author":"Marin","year":"2022","journal-title":"J Infect Dis"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MOP.0000000000001112","article-title":"Prevention of pneumococcal infections in childhood: two decades of progress.","volume":"34","author":"Walter","year":"2022","journal-title":"Curr Opin Pediatr"},{"key":"R42-20250614","doi-asserted-by":"crossref","first-page":"e0269916","DOI":"10.1371\/journal.pone.0269916","article-title":"Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States.","volume":"17","author":"Pawaskar","year":"2022","journal-title":"PLoS One"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:01:48Z","timestamp":1749945708000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004254","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2024,2,16]]}}}